Alaunos Therapeutics Inc (TCRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2004 | 06-2004 | 03-2004 | 12-2003 | 09-2003 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,056 | N/A | N/A | -36 | N/A |
| Depreciation Amortization | 25 | N/A | N/A | 1 | N/A |
| Accounts payable and accrued liabilities | 203 | N/A | N/A | 9 | N/A |
| Other Working Capital | 469 | N/A | N/A | 9 | N/A |
| Other Operating Activity | -203 | -6 | -1 | 9 | -9 |
| Operating Cash Flow | $-2,562 | $-6 | $-1 | $-9 | $-9 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -133 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-133 | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | -1 | -1 |
| Common Stock Issued | 4,500 | 6 | 6 | 10 | 10 |
| Financing Cash Flow | $4,500 | $6 | $6 | $9 | $9 |
| Beginning Cash Position | 402 | 0 | 0 | 0 | 0 |
| End Cash Position | 2,207 | 0 | 5 | 0 | 0 |
| Net Cash Flow | $1,805 | $0 | $5 | $0 | $0 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,562 | -6 | -1 | -9 | -9 |
| Capital Expenditure | -133 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -2,696 | -6 | -1 | -9 | -9 |